FASLG and neoplasm: Particularly, Tregs expressing Fas ligand (FasL) has been shown to selectively induce apoptosis in CD8+ T cells within tumor microenvironments, including head and neck squamous cell carcinoma (HNSCC) and hepatocellular carcinoma (HCC) [24,25].